Nu-Med Plus, Inc.
NUMD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $13 | $13 | $23 |
| Gross Profit | $0 | -$13 | -$13 | -$23 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $63 | $66 | $180 | $830 |
| SG&A Expenses | $63 | $121 | $180 | $830 |
| Sales & Mktg Exp. | $0 | $55 | $0 | $0 |
| Other Operating Expenses | $0 | $42 | $2 | $9 |
| Operating Expenses | $63 | $121 | $182 | $839 |
| Operating Income | -$63 | -$121 | -$182 | -$839 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$5 | -$5 | $52 | $9 |
| Pre-Tax Income | -$68 | -$126 | -$130 | -$830 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$68 | -$126 | -$130 | -$830 |
| % Margin | – | – | – | – |
| EPS | -0.001 | -0.002 | -0.002 | -0.011 |
| % Growth | 46.7% | 6.3% | 85.8% | – |
| EPS Diluted | -0.001 | -0.002 | -0.002 | -0.011 |
| Weighted Avg Shares Out | 83,548 | 81,722 | 79,951 | 73,374 |
| Weighted Avg Shares Out Dil | 83,548 | 81,674 | 79,951 | 73,374 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5 | $5 | $1 | $0 |
| Depreciation & Amortization | $63 | $2 | $10 | $21 |
| EBITDA | $0 | -$118 | -$172 | -$818 |
| % Margin | – | – | – | – |